Back to Journals » OncoTargets and Therapy » Volume 10

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction

Total article views   HTML views PDF downloads Totals
10,194 Dovepress* 9,051+ 1,170 10,221
PubMed Central* 1,143 275 1,418
Totals 10,194 1,445 11,639
*Since 29 June 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 1 2

View citations on PubMed Central and Google Scholar